References
- American Cancer Society (1999-2000). Breast Cancer Facts and Figures BRCAFF99
- Andersen TI, Holm R, Nesland JM, et al (1993). Prognostic significance of TP53 alterations in breast carcinoma. Br J Cancer, 69, 540-8.
- Davidoff AM, Kerns BJM (1991). Maintenance of p53 alterations throughout breast cancer progression. Cancer Res, 51, 2605-10.
- Dhingra K, Hortobagyi GN (1996). TITLE????. Semin Oncol, 23, 436-45.
- Gretarsdottit S, Tryggvadottir L, Jonasson JC, et al (1996). TP53 mutation analyses on breast carcinomas. A study of paraffinembedded archival material. Br J Cancer, 74, 555-61. https://doi.org/10.1038/bjc.1996.400
- Harris CC (1996). P53 tumor suppressor gene: At the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment. Environ Health Perspect, 104, 435-9. https://doi.org/10.1289/ehp.96104s3435
- Hollstein M, Sidransky D, Vogelstein B, et al (1991). p53 mutations in human cancers. Science, 253, 49-53. https://doi.org/10.1126/science.1905840
- Levine AJ, Momand J, Finley CA (1991). The p53 tumour suppressor gene. Nature, 351, 453-6. https://doi.org/10.1038/351453a0
- Mabrouk I, Baccouche S, El-Abed R, et al (2003). No evidence of correlation between p 53 codon 72 polymorphism and risk of bladder or breast carcinoma in Tunisian patients. Ann NY Acad Sci, 1010, 764-70. https://doi.org/10.1196/annals.1299.137
- Madrigal L (1994). Twinning rates in admixed Costa Rican populations. Am J Hum Biol, 6, 215-8. https://doi.org/10.1002/ajhb.1310060209
- Sambrook J, Russel DW (2000). Molecular cloning: a laboratory manual in: Irwin N (ed) Cold Spring Harbor Press, NY. Science
- Smardova J, Nemajerova A, Trbusek M, et al (2001). Rare somatic p53 mutation identification in breast cancer - A case report. Tumor Biology, 22, 59-66. https://doi.org/10.1159/000050597
- Thoralacius S, Borrensen AL, Eyfjord JE (1993). Somatic p53 mutations in human breast carcinomas in an Icelandic population- a prognostic factor. Cancer Res, 53, 1637-41.
- Mancuso T (1995). Mutation frequencies at codon 248 of the p53 tumor suppressor gene are not increased in colon cancer cell lines with the RER+ phenotype. PLEASE CHECK!!!Oxford university press, ?, 3643-8.
- Varley JM, Brammer WJ (1991). Loss of chromosome 17 p13 sequences and mutation of p53 in human breast carcinomas. Oncogene, 6, 413-21.
- Zubo P, Stanclova A, Kajo K, et al (2009). The p53 codon 72 exon 4 BstUI polymorphism and endometrial cancer in Caucasian women. Clin Trans Res, 76, 173-83.
Cited by
- Lack of Association of Intron 3 16 bp Polymorphism of TP53 with Breast Cancer among Iranian-Azeri Patients vol.15, pp.6, 2014, https://doi.org/10.7314/APJCP.2014.15.6.2631
- Association of TP53 PIN3 polymorphism with breast cancer in Moroccan population vol.35, pp.12, 2014, https://doi.org/10.1007/s13277-014-2556-y